Launch week offerEnds in00h00m00s

annual Promonthly Pro

Marco Seehawer

Group leader

Georg-Speyer-Haus

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Cell Biology Cell Biology professors in Germany

Articles (19)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Melissa Ronan

Broad Institute

UNITED STATES

View details

Jun Nishida

Dana-Farber Cancer Institute

UNITED STATES

View details

Iros Barozzi

Assistant Professor

Medical University of Vienna

AUSTRIA

View details

Kendell Clement

Assistant Professor

University of Utah

UNITED STATES

View details

Kornelia Polyak

Dana-Farber Cancer Institute

UNITED STATES

View details

Martin Eilers

Professor

University of Würzburg

GERMANY

View details

Christina Curtis

Professor of Medicine & Genetics

Stanford University

UNITED STATES

View details

Gordon Freeman

Professor

Dana-Farber Cancer Institute

UNITED STATES

View details

Marie-Anne Goyette

Principal investigator

Université de Montréal

CANADA

View details

Sarah Sammons

Assistant Professor

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marco Seehawer

Research Interests

Make your next move.

Explore related searches

Articles (19)

Whole-genome doubling drives immune evasion by silencing antigen presentation.

Histone H4 lysine 20 tri-methylation safeguards breast cancer lineage fidelity and unfolded protein response

Evaluation of targeted and immune combination therapies in a rat model of hormone receptor–positive breast cancer

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6

HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies

Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.

Epigenetic drivers of metalloproteinases and metastasis

KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage

Cell Death and Survival Mechanisms in Cholangiocarcinogenesis

Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3

Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.

Development and characterization of kinase sparing TPX2-tethering Aurora kinase A ligands for cancer therapy

KDM4C histone demethylase connects redox balance to chromatin remodeling via histone H3 tail clipping

Midkine as a driver of age-related changes and increase in mammary tumorigenesis

The role of whole genome doubling in immune escape in TNBC

ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer

MYC determines lineage commitment in KRAS-driven primary liver cancer development.

Heterogeneity and transcriptional drivers of triple-negative breast cancer

JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Collaborators (10)

Melissa Ronan

Jun Nishida

Iros Barozzi

Kendell Clement

Kornelia Polyak

Martin Eilers

Christina Curtis

Gordon Freeman

Marie-Anne Goyette

Sarah Sammons

Make your next move.